Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   intracranial aneurysm
  

Disease ID 269
Disease intracranial aneurysm
Definition
Abnormal outpouching in the wall of intracranial blood vessels. Most common are the saccular (berry) aneurysms located at branch points in CIRCLE OF WILLIS at the base of the brain. Vessel rupture results in SUBARACHNOID HEMORRHAGE or INTRACRANIAL HEMORRHAGES. Giant aneurysms (>2.5 cm in diameter) may compress adjacent structures, including the OCULOMOTOR NERVE. (From Adams et al., Principles of Neurology, 6th ed, p841)
Synonym
aneurysm intracranial
aneurysm, intracranial
aneurysms intracranial
aneurysms, intracranial
cranial aneurysm
intracranial aneurysm (disorder)
intracranial aneurysm [disease/finding]
intracranial aneurysm, nos
intracranial aneurysms
DOID
UMLS
C0007766
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:65)
C0032000  |  pituitary adenoma  |  6
C0022679  |  cystic kidney  |  4
C0001430  |  adenoma  |  4
C0014118  |  endocarditis  |  4
C0026654  |  moyamoya disease  |  3
C0041341  |  tuberous sclerosis  |  3
C0026654  |  moyamoya  |  3
C0040053  |  thrombosis  |  3
C0003486  |  aortic aneurysm  |  3
C0025286  |  meningiomas  |  2
C0007282  |  carotid stenosis  |  2
C0007785  |  cerebral ischemia  |  2
C0022658  |  kidney disease  |  2
C0002895  |  sickle cell disease  |  2
C0032000  |  pituitary adenomas  |  2
C0162872  |  thoracic aortic aneurysm  |  2
C0003857  |  arteriovenous malformation  |  2
C0085413  |  autosomal dominant polycystic kidney  |  2
C0007282  |  carotid artery stenosis  |  2
C0085413  |  autosomal dominant polycystic kidney disease  |  2
C0017636  |  glioblastoma  |  1
C0031036  |  polyarteritis nodosa  |  1
C0014121  |  infective endocarditis  |  1
C0004943  |  behcet's disease  |  1
C0011570  |  depression  |  1
C0022398  |  hyper-ige syndrome  |  1
C0041341  |  tuberous sclerosis complex  |  1
C0409974  |  lupus erythematosus  |  1
C0162872  |  thoracic aortic aneurysms  |  1
C0028866  |  oculomotor nerve palsy  |  1
C0206734  |  hemangioblastoma  |  1
C0206734  |  hemangioblastomas  |  1
C0010495  |  cutis laxa  |  1
C0003467  |  anxiety  |  1
C0009326  |  collagen disorders  |  1
C0003486  |  aortic aneurysms  |  1
C0034063  |  pulmonary edema  |  1
C0349604  |  intracranial meningioma  |  1
C0085278  |  antiphospholipid syndrome  |  1
C0025286  |  meningioma  |  1
C0162871  |  abdominal aortic aneurysm  |  1
C0524812  |  intracranial hypotension  |  1
C0020255  |  hydrocephalus  |  1
C1290398  |  cerebral artery aneurysm  |  1
C1260386  |  glucocorticoid-remediable aldosteronism  |  1
C2697932  |  loeys-dietz syndrome  |  1
C0014122  |  infectious endocarditis  |  1
C0338585  |  carotid artery dissection  |  1
C0016052  |  fibromuscular dysplasia  |  1
C0040053  |  thrombus  |  1
C0022116  |  ischemia  |  1
C0152021  |  congenital heart disease  |  1
C0302592  |  cervical ca  |  1
C0349604  |  intracranial meningiomas  |  1
C0011860  |  type 2 diabetes  |  1
C0009782  |  connective tissue disease  |  1
C0547030  |  visual disturbance  |  1
C0018799  |  heart disease  |  1
C0024141  |  systemic lupus erythematosus  |  1
C0014121  |  bacterial endocarditis  |  1
C0011847  |  diabetes  |  1
C1621958  |  glioblastoma multiforme  |  1
C0151311  |  cranial nerve palsy  |  1
C0007273  |  carotid artery disease  |  1
C0085548  |  autosomal recessive polycystic kidney disease  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:6)
CNNM2  |  54805  |  GWASCAT
BOLL  |  66037  |  GWASCAT
EDNRA  |  1909  |  GWASCAT
NCF1  |  653361  |  CTD_human
CDKN2B-AS1  |  100048912  |  GWASCAT
STARD13  |  90627  |  GWASCAT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:41)
2022  |  ENG  |  infer
4018  |  LPA  |  infer
23495  |  TNFRSF13B  |  infer
1636  |  ACE  |  infer
217  |  ALDH2  |  infer
9826  |  ARHGEF11  |  infer
51272  |  BET1L  |  infer
66037  |  BOLL  |  infer
875  |  CBS  |  infer
1029  |  CDKN2A  |  infer
1030  |  CDKN2B  |  infer
54805  |  CNNM2  |  infer
1278  |  COL1A2  |  infer
1281  |  COL3A1  |  infer
1282  |  COL4A1  |  infer
1719  |  DHFR  |  infer
1909  |  EDNRA  |  infer
2201  |  FBN2  |  infer
9446  |  GSTO1  |  infer
3339  |  HSPG2  |  infer
3569  |  IL6  |  infer
9922  |  IQSEC1  |  infer
122953  |  JDP2  |  infer
3816  |  KLK1  |  infer
4524  |  MTHFR  |  infer
4548  |  MTR  |  infer
4846  |  NOS3  |  infer
1728  |  NQO1  |  infer
5334  |  PLCL1  |  infer
5981  |  RFC1  |  infer
26766  |  RNU105C  |  infer
100130537  |  RPL31P26  |  infer
646583  |  RPS4XP18  |  infer
157708  |  SEC11B  |  infer
64321  |  SOX17  |  infer
90627  |  STARD13  |  infer
6948  |  TCN2  |  infer
7124  |  TNF  |  infer
1462  |  VCAN  |  infer
7076  |  TIMP1  |  infer
7077  |  TIMP2  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:140)
100048912  |  CDKN2B-AS1  |  DISEASES
282706  |  DAOA-AS1  |  DISEASES
4706  |  NDUFAB1  |  DISEASES
8086  |  AAAS  |  DISEASES
10857  |  PGRMC1  |  DISEASES
4313  |  MMP2  |  DISEASES
10404  |  CPQ  |  DISEASES
7040  |  TGFB1  |  DISEASES
51200  |  CPA4  |  DISEASES
5054  |  SERPINE1  |  DISEASES
11216  |  AKAP10  |  DISEASES
6347  |  CCL2  |  DISEASES
1277  |  COL1A1  |  DISEASES
4633  |  MYL2  |  DISEASES
4015  |  LOX  |  DISEASES
5732  |  PTGER2  |  DISEASES
2354  |  FOSB  |  DISEASES
22863  |  ATG14  |  DISEASES
10365  |  KLF2  |  DISEASES
968  |  CD68  |  DISEASES
5908  |  RAP1B  |  DISEASES
2006  |  ELN  |  DISEASES
59272  |  ACE2  |  DISEASES
10343  |  PKDREJ  |  DISEASES
9038  |  TAAR5  |  DISEASES
55901  |  THSD1  |  DISEASES
3569  |  IL6  |  DISEASES
153090  |  DAB2IP  |  DISEASES
23495  |  TNFRSF13B  |  DISEASES
23531  |  MMD  |  DISEASES
2201  |  FBN2  |  DISEASES
10847  |  SRCAP  |  DISEASES
3553  |  IL1B  |  DISEASES
9424  |  KCNK6  |  DISEASES
3977  |  LIFR  |  DISEASES
2121  |  EVC  |  DISEASES
1462  |  VCAN  |  DISEASES
6595  |  SMARCA2  |  DISEASES
8034  |  SLC25A16  |  DISEASES
7078  |  TIMP3  |  DISEASES
122953  |  JDP2  |  DISEASES
463  |  ZFHX3  |  DISEASES
8533  |  COPS3  |  DISEASES
5972  |  REN  |  DISEASES
9922  |  IQSEC1  |  DISEASES
6423  |  SFRP2  |  DISEASES
1030  |  CDKN2B  |  DISEASES
60496  |  AASDHPPT  |  DISEASES
10398  |  MYL9  |  DISEASES
23657  |  SLC7A11  |  DISEASES
10750  |  GRAP  |  DISEASES
55364  |  IMPACT  |  DISEASES
9510  |  ADAMTS1  |  DISEASES
22808  |  MRAS  |  DISEASES
1636  |  ACE  |  DISEASES
8209  |  C21orf33  |  DISEASES
6285  |  S100B  |  DISEASES
7412  |  VCAM1  |  DISEASES
1359  |  CPA3  |  DISEASES
28999  |  KLF15  |  DISEASES
56979  |  PRDM9  |  DISEASES
1278  |  COL1A2  |  DISEASES
64321  |  SOX17  |  DISEASES
4846  |  NOS3  |  DISEASES
58157  |  NGB  |  DISEASES
114795  |  TMEM132B  |  DISEASES
1381  |  CRABP1  |  DISEASES
4314  |  MMP3  |  DISEASES
5347  |  PLK1  |  DISEASES
1292  |  COL6A2  |  DISEASES
1632  |  ECI1  |  DISEASES
3592  |  IL12A  |  DISEASES
1281  |  COL3A1  |  DISEASES
2548  |  GAA  |  DISEASES
64805  |  P2RY12  |  DISEASES
57599  |  WDR48  |  DISEASES
11280  |  SCN11A  |  DISEASES
10098  |  TSPAN5  |  DISEASES
197259  |  MLKL  |  DISEASES
5340  |  PLG  |  DISEASES
572  |  BAD  |  DISEASES
5655  |  KLK10  |  DISEASES
1909  |  EDNRA  |  DISEASES
8560  |  DEGS1  |  DISEASES
4018  |  LPA  |  DISEASES
5932  |  RBBP8  |  DISEASES
9622  |  KLK4  |  DISEASES
4843  |  NOS2  |  DISEASES
6401  |  SELE  |  DISEASES
10509  |  SEMA4B  |  DISEASES
5587  |  PRKD1  |  DISEASES
3984  |  LIMK1  |  DISEASES
25818  |  KLK5  |  DISEASES
22978  |  NT5C2  |  DISEASES
113675  |  SDSL  |  DISEASES
392636  |  AGMO  |  DISEASES
10166  |  SLC25A15  |  DISEASES
3921  |  RPSA  |  DISEASES
5265  |  SERPINA1  |  DISEASES
4763  |  NF1  |  DISEASES
1284  |  COL4A2  |  DISEASES
1066  |  CES1  |  DISEASES
10367  |  MICU1  |  DISEASES
22909  |  FAN1  |  DISEASES
5455  |  POU3F3  |  DISEASES
9722  |  NOS1AP  |  DISEASES
1291  |  COL6A1  |  DISEASES
9826  |  ARHGEF11  |  DISEASES
5737  |  PTGFR  |  DISEASES
27063  |  ANKRD1  |  DISEASES
4318  |  MMP9  |  DISEASES
6572  |  SLC18A3  |  DISEASES
3561  |  IL2RG  |  DISEASES
3339  |  HSPG2  |  DISEASES
19  |  ABCA1  |  DISEASES
7046  |  TGFBR1  |  DISEASES
84909  |  C9orf3  |  DISEASES
1282  |  COL4A1  |  DISEASES
11278  |  KLF12  |  DISEASES
57380  |  MRS2  |  DISEASES
427  |  ASAH1  |  DISEASES
11202  |  KLK8  |  DISEASES
87  |  ACTN1  |  DISEASES
4239  |  MFAP4  |  DISEASES
23164  |  MPRIP  |  DISEASES
9718  |  ECE2  |  DISEASES
93166  |  PRDM6  |  DISEASES
2160  |  F11  |  DISEASES
140469  |  MYO3B  |  DISEASES
1029  |  CDKN2A  |  DISEASES
130507  |  UBR3  |  DISEASES
50863  |  NTM  |  DISEASES
7124  |  TNF  |  DISEASES
93649  |  MYOCD  |  DISEASES
9734  |  HDAC9  |  DISEASES
80235  |  PIGZ  |  DISEASES
2257  |  FGF12  |  DISEASES
64856  |  VWA1  |  DISEASES
8260  |  NAA10  |  DISEASES
102723508  |  KANTR  |  DISEASES
Locus(Waiting for update.)
Disease ID 269
Disease intracranial aneurysm
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:57)
HP:0002138  |  Subarachnoid hemorrhage  |  35
HP:0002617  |  Aneurysmal dilatation  |  24
HP:0002893  |  Pituitary adenoma  |  6
HP:0001297  |  Cerebral vascular events  |  6
HP:0002140  |  Ischemic stroke  |  5
HP:0100584  |  Endocarditis  |  4
HP:0000113  |  Polycystic kidney dysplasia  |  4
HP:0100546  |  Narrowing of carotid artery  |  4
HP:0001342  |  Intracerebral hemorrhage  |  3
HP:0002315  |  Headaches  |  3
HP:0011856  |  Pica  |  3
HP:0002664  |  Neoplasia  |  3
HP:0004942  |  Aortic aneurysm  |  3
HP:0001647  |  Bicuspid aortic valve  |  2
HP:0030692  |  Brain tumor  |  2
HP:0006689  |  Bacterial endocarditis  |  2
HP:0001907  |  Thromboembolic disease  |  2
HP:0000475  |  Broad neck  |  2
HP:0012727  |  Thoracic aortic aneurysm  |  2
HP:0002637  |  Brain ischemia  |  2
HP:0100026  |  Arteriovenous malformation  |  2
HP:0012721  |  Venous malformations  |  2
HP:0002858  |  Mengiomia  |  1
HP:0000739  |  Anxiety  |  1
HP:0001649  |  Tachycardia  |  1
HP:0030907  |  Thunderclap headache  |  1
HP:0002725  |  Systemic lupus erythematosus  |  1
HP:0002170  |  Intracranial hemorrhage  |  1
HP:0003510  |  Proportionate dwarfism  |  1
HP:0009733  |  Glioma  |  1
HP:0000973  |  Dermatomegaly  |  1
HP:0012474  |  Obstructed carotid artery  |  1
HP:0010797  |  Hemangioblastoma  |  1
HP:0004947  |  Arteriovenous fistula  |  1
HP:0100598  |  Pulmonary oedema  |  1
HP:0012158  |  Carotid artery dissection  |  1
HP:0001695  |  Cardiac arrest  |  1
HP:0000238  |  Nonsyndromal hydrocephalus  |  1
HP:0012722  |  Heart block  |  1
HP:0012735  |  Coughing  |  1
HP:0100009  |  Intracranial meningioma  |  1
HP:0005290  |  Small internal carotid artery  |  1
HP:0000969  |  Dropsy  |  1
HP:0009829  |  Phocomelia  |  1
HP:0002045  |  Abnormally low body temperature  |  1
HP:0012174  |  Glioblastoma multiforme  |  1
HP:0001709  |  Complete heart block  |  1
HP:0011672  |  Cardiac myxoma  |  1
HP:0012641  |  Decreased intracranial pressure  |  1
HP:0001680  |  Coarctation of aorta  |  1
HP:0000716  |  Depression  |  1
HP:0012246  |  Oculomotor nerve palsy  |  1
HP:0005116  |  Arterial tortuosity  |  1
HP:0004953  |  Abdominal aortic aneurysm  |  1
HP:0100843  |  Glioblastoma  |  1
HP:0004944  |  Cerebral artery aneurysm  |  1
HP:0006824  |  Cranial nerve palsy  |  1
Disease ID 269
Disease intracranial aneurysm
Manually Symptom
UMLS  | Name(Total Manually Symptoms:18)
C2700478  |  meningioma
C2096315  |  headache
C1962958  |  hematoma
C0750974  |  primary brain tumors
C0342751  |  acid maltase deficiency
C0265110  |  cerebral vasospasm
C0042373  |  vascular disease
C0040053  |  thrombosis
C0038525  |  subarachnoid hemorrhage
C0037763  |  spasm
C0028866  |  oculomotor nerve paralysis
C0028866  |  oculomotor nerve palsy
C0018989  |  hemiparesis
C0014544  |  epileptic seizure
C0014544  |  epilepsy
C0014130  |  endocrinopathy
C0006118  |  brain tumour
C0005586  |  bipolar disorder
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:7)
C0038525  |  subarachnoid hemorrhage  |  32
C0040053  |  thrombosis  |  3
C0018681  |  headache  |  3
C0028866  |  oculomotor nerve palsy  |  1
C0265110  |  cerebral vasospasm  |  1
C0018944  |  hematoma  |  1
C0025286  |  meningioma  |  1
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:60)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs107273722961961100048912CDKN2B-AS1umls:C0007766BeFreeHowever, the metaanalysis yielded genomewide significance for SNP on chromosome 9p (CDKN2BAS; rs6475606; P=3.6×10(-8)) and provided further evidence to support the previously reported association of IA with SNP in SOX17 on chromosome 8q (rs1072737; P=8.7×10(-5)).0.1213572092012NA854501764TG
rs1073337625256182100048912CDKN2B-AS1umls:C0007766BeFreeGenome-wide evidence of association was detected in the discovery sample on chromosome 9 (CDKN2BAS; rs10733376: P<1.0×10(-11)), in a gene previously associated with IA.0.1213572092015CDKN2B-AS1922114470GC
rs1073337625256182100048912CDKN2B-AS1umls:C0007766GWASCATGenome-wide evidence of association was detected in the discovery sample on chromosome 9 (CDKN2BAS; rs10733376: P<1.0×10(-11)), in a gene previously associated with IA.0.1213572092015CDKN2B-AS1922114470GC
rs1075727222286173100048912CDKN2B-AS1umls:C0007766GWASCATAdditionally, we successfully replicated and validated rs10757272 on CDKN2BAS at chromosome 9p21.3 (combined P-value = 1.55 × 10(-7); odds ratio = 1.21) to be significantly associated with IA as previously reported.0.1213572092012CDKN2B-AS1922088261CT
rs1075727222286173100048912CDKN2B-AS1umls:C0007766BeFreeAdditionally, we successfully replicated and validated rs10757272 on CDKN2BAS at chromosome 9p21.3 (combined P-value = 1.55 × 10(-7); odds ratio = 1.21) to be significantly associated with IA as previously reported.0.1213572092012CDKN2B-AS1922088261CT
rs109584091899778664321SOX17umls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.0052769482008NA854414531GA
rs124134092036413754805CNNM2umls:C0007766GWASCATGenome-wide association study of intracranial aneurysm identifies three new risk loci.0.122010CNNM210102959339GA
rs1333040203956131029CDKN2Aumls:C0007766GAD[Sequencing of CDKN2A, CDKN2B, and CDKN2BAS revealed additional SNPs, and their associations with IA were also tested.]0.0073725382010CDKN2B-AS1922083405CT
rs1333040189977861030CDKN2Bumls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.0071010962008CDKN2B-AS1922083405CT
rs133304020364137100048912CDKN2B-AS1umls:C0007766GWASCATGenome-wide association study of intracranial aneurysm identifies three new risk loci.0.1213572092010CDKN2B-AS1922083405CT
rs133304020395613100048912CDKN2B-AS1umls:C0007766BeFreeA region between introns 7 and 15 of CDKN2BAS carrying the rs1333040-T allele may confer risk for IA.0.1213572092010CDKN2B-AS1922083405CT
rs1333040203956131030CDKN2Bumls:C0007766GAD[Sequencing of CDKN2A, CDKN2B, and CDKN2BAS revealed additional SNPs, and their associations with IA were also tested.]0.0071010962010CDKN2B-AS1922083405CT
rs133304018997786100048912CDKN2B-AS1umls:C0007766GWASCATSusceptibility loci for intracranial aneurysm in European and Japanese populations.0.1213572092008CDKN2B-AS1922083405CT
rs1333040189977861029CDKN2Aumls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.0073725382008CDKN2B-AS1922083405CT
rs1799983180465004846NOS3umls:C0007766BeFreePolymorphism in exon 7 of the endothelial nitric oxide synthase gene G894T seems to be a possible risk factor for intracranial aneurysm rupture.0.0974456822008NOS37150999023TG
rs1930095206137663984LIMK1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0010857672010NA9108592638TC
rs1930095206137662006ELNumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0087060032010NA9108592638TC
rs193009520613766392636AGMOumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0002714422010NA9108592638TC
rs1930095206137669922IQSEC1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010NA9108592638TC
rs1930095206137669826ARHGEF11umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010NA9108592638TC
rs22805432228617351272BET1Lumls:C0007766GAD[Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA.]0.0023670322012BET1L11203788CT
rs41322052156580984846NOS3umls:C0007766BeFreeAmong patients with aneurysms, those with heterozygous (T/C) endothelial nitric oxide synthase (eNOS) T-786C single nucleotide polymorphism (SNP), a mutation reducing endothelial nitric oxide synthesis, are reported to have larger ruptured intracranial aneurysms (IAs) than those with homozygous (C/C or T/T) genotype.0.0974456822005NOS37150993018CT
rs41322052150911094846NOS3umls:C0007766BeFreeIn this prospective clinical study involving 141 participants, we used gene microarray technology to demonstrate that the eNOS gene intron-4 27-base pair variable number tandem repeat polymorphism (eNOS 27 VNTR) predicts susceptibility to intracranial aneurysm rupture, while the eNOS gene promoter T-786C single nucleotide polymorphism (eNOS T-786C SNP) predicts susceptibility to post-subarachnoid hemorrhage vasospasm.0.0974456822004NOS37150993018CT
rs41322052145763734846NOS3umls:C0007766BeFreeEndothelial nitric oxide synthase T-786C single nucleotide polymorphism: a putative genetic marker differentiating small versus large ruptured intracranial aneurysms.0.0974456822003NOS37150993018CT
rs42524194267061278COL1A2umls:C0007766BeFreeA coding polymorphism (rs42524) in COL1A2 has previously been associated with intracranial aneurysms.0.0141784482009COL1A2794413927CA,G,T
rs42524228156321278COL1A2umls:C0007766BeFreeIn this study, we investigated the association of rs42524 in the alpha-2 type I collagen (COL1A2) gene, which has been identified as a risk variant for intracranial aneurysm, with nAMD and PCV in a Han Chinese population.0.0141784482012COL1A2794413927CA,G,T
rs42524190357201278COL1A2umls:C0007766GAD[Polymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population.]0.0141784482008COL1A2794413927CA,G,T
rs42524190357201278COL1A2umls:C0007766BeFreePolymorphism rs42524 of COL1A2 and sporadic intracranial aneurysms in the Chinese population.0.0141784482008COL1A2794413927CA,G,T
rs462817220613766392636AGMOumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0002714422010AGMO715455525TG
rs4628172206137669922IQSEC1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010AGMO715455525TG
rs4628172206137663984LIMK1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0010857672010AGMO715455525TG
rs4628172206137662006ELNumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0087060032010AGMO715455525TG
rs4628172206137669826ARHGEF11umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010AGMO715455525TG
rs49341990716512SERPINA3umls:C0007766BeFreePolymorphism rs4934 of SERPINA3 and sporadic intracranial aneurysms in the Chinese population.0.0029099162010SERPINA31494614466GA
rs647560622961961100048912CDKN2B-AS1umls:C0007766GWASCATHowever, the metaanalysis yielded genomewide significance for SNP on chromosome 9p (CDKN2BAS; rs6475606; P=3.6×10(-8)) and provided further evidence to support the previously reported association of IA with SNP in SOX17 on chromosome 8q (rs1072737; P=8.7×10(-5)).0.1213572092012CDKN2B-AS1922081851CT
rs647560622961961100048912CDKN2B-AS1umls:C0007766BeFreeHowever, the metaanalysis yielded genomewide significance for SNP on chromosome 9p (CDKN2BAS; rs6475606; P=3.6×10(-8)) and provided further evidence to support the previously reported association of IA with SNP in SOX17 on chromosome 8q (rs1072737; P=8.7×10(-5)).0.1213572092012CDKN2B-AS1922081851CT
rs67122286173217ALDH2umls:C0007766GAD[Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA.]0.0023670322012ALDH212111803962GA
rs6842241222861731909EDNRAumls:C0007766GAD[Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA.]0.1229099162012EDNRA4147479667CA
rs6842241222861731909EDNRAumls:C0007766GWASCATGenome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA.0.1229099162012EDNRA4147479667CA
rs700651189977865334PLCL1umls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.0023670322008BOLL2197766990GA
rs7006511899778666037BOLLumls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.1223670322008BOLL2197766990GA
rs7006511899778666037BOLLumls:C0007766GWASCATSusceptibility loci for intracranial aneurysm in European and Japanese populations.0.1223670322008BOLL2197766990GA
rs7550260206137669826ARHGEF11umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010ARHGEF111157031869CA
rs7550260206137669922IQSEC1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010ARHGEF111157031869CA
rs7550260206137662006ELNumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0087060032010ARHGEF111157031869CA
rs7550260206137663984LIMK1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0010857672010ARHGEF111157031869CA
rs755026020613766392636AGMOumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0002714422010ARHGEF111157031869CA
rs7781293206137662006ELNumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0087060032010AGMO715451358CA
rs7781293206137663984LIMK1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0010857672010AGMO715451358CA
rs7781293206137669922IQSEC1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010AGMO715451358CA
rs7781293206137669826ARHGEF11umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010AGMO715451358CA
rs778129320613766392636AGMOumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0002714422010AGMO715451358CA
rs92985061899778664321SOX17umls:C0007766GAD[Susceptibility loci for intracranial aneurysm in European and Japanese populations.]0.0052769482008NA854524964AG
rs93152042036413790627STARD13umls:C0007766GAD[We identified three new loci showing strong evidence for association with intracranial aneurysms in the combined dataset, including intervals near RBBP8 on 18q11.2 (odds ratio (OR) = 1.22, P = 1.1 x 10(-12)), STARD13-KL on 13q13.1 (OR = 1.20, P = 2.5 x 10(-9)) and a gene-rich region on 10q24.32 (OR = 1.29, P = 1.2 x 10(-9)).]0.1226384742010STARD131333119700CT
rs93152042036413790627STARD13umls:C0007766GWASCATWe identified three new loci showing strong evidence for association with intracranial aneurysms in the combined dataset, including intervals near RBBP8 on 18q11.2 (odds ratio (OR) = 1.22, P = 1.1 x 10(-12)), STARD13-KL on 13q13.1 (OR = 1.20, P = 2.5 x 10(-9)) and a gene-rich region on 10q24.32 (OR = 1.29, P = 1.2 x 10(-9)).0.1226384742010STARD131333119700CT
rs9864101206137662006ELNumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0087060032010IQSEC1313148884CT
rs986410120613766392636AGMOumls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0002714422010IQSEC1313148884CT
rs9864101206137669922IQSEC1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010IQSEC1313148884CT
rs9864101206137663984LIMK1umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0010857672010IQSEC1313148884CT
rs9864101206137669826ARHGEF11umls:C0007766BeFreeConsequently, five SNPs (P=1.31 × 10(-5) for rs1930095 of intergenic region; P=1.32 × 10(-5) for rs4628172 of TMEM195; P=2.78 × 10(-5) for rs7781293 of TMEM195; P=4.93 × 10(-5) for rs7550260 of ARHGEF11; and P=3.63 × 10(-5) for rs9864101 of IQSEC1) with probabilities of being false positives <0.5 were associated with IA in Japanese population, and the susceptibility genes could have a role in actin remodeling in the ELN/LIMK pathway.0.0026384742010IQSEC1313148884CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Chemical(Total Drugs:3)
CUI ChemicalName ChemicalID CasRN DiseaseName DiseaseID DirectEvidence PubMedIDs
C0007766amphetamineD000661300-62-9intracranial aneurysmMESH:D002532marker/mechanism12604995
C0007766nimodipineD00955366085-59-4intracranial aneurysmMESH:D002532therapeutic3054619
C0007766tranexamic acidD0141481197-18-8intracranial aneurysmMESH:D002532therapeutic7000850
FDA approved drug and dosage information(Total Drugs:1)
DiseaseID Drug_name active_ingredients strength Dosage Form/Route Marketing Status TE code RLD RS
MESH:D002532lystedatranexamic acid650MGTABLET;ORALPrescriptionABYesYes
FDA labeling changes(Total Drugs:1)
DiseaseID Pediatric_Labeling_Date Trade_Name Generic_Name_or_Proper_Name Indications Studied Label Changes Summary Product Labeling BPCA(B) PREA(P) BPCA(B) and PREA(P) Pediatric Rule (R) Sponsor Pediatric Exclusivity Granted Date NNPS
MESH:D00253208/21/2013lystedatranexamic acidTreatment of cyclic heavy menstrual bleedingIndicated for women of reproductive age. It is not intended for use in premenarcheal girls Information on PK studyPostmarketing study-P--Ferring-FALSE'-